Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials.
暂无分享,去创建一个
P. Moreau | H. Avet-Loiseau | G. Marit | C. Mathiot | T. Facon | J. Harousseau | F. Guilhot | C. Doyen | M. Attal | L. Garderet | C. Hulin | F. Garban | T. Lamy | M. Michallet | L. Voillat | N. Ketterer | C. Charbonnel